Patil VM, Noronha V, Menon N, Singh A, et al. Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. J Clin Oncol 2023 Jan 27:JCO2200980. doi: 10.1200/JCO.22.00980.
PMID: 36706347